The likely collapse of AbbVie Incs  billion agreement to buy Shire PLC leaves two global drug companies in need of new independent courses and investors and Wall Street bankers smarting from losses and fees they wont collect Since AbbVie said late Wednesday that taxsystem changes prompted its board to withdraw its support for the deal fallout from the decision has come into sharper focus  Breaking
  